Cleveland BioLabs, Inc: Cleveland Biolabs Announces Formation and Financing of an Anti-Aging Joint Venture

16:56 EDT 14 Aug 2018 | FinanzNachrichten

Goal is to Develop and Commercialize Entolimod and Other Compounds for Anti-aging Applications BUFFALO, NY / ACCESSWIRE / August 14, 2018 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported for...

More From BioPortfolio on "Cleveland BioLabs, Inc: Cleveland Biolabs Announces Formation and Financing of an Anti-Aging Joint Venture"